Manufacturing alerts and issues at Teva, Pfizer, and more
US states sue generic firms over 'inflated' prices - PMLiVE
Mylan-Pfizer off-patent merger boosts Teva - Globes
Bad news for Momenta and Pfizer is a blessing for Teva
Pfizer Wins Lyrica Patent Infringement Case Against Teva and Other Generic Drug Manufacturers | American University Intellectual Property Brief
Pfizer gets $2.15 billion settlement
Israel's Teva, more than 30 other firms worldwide to start making Pfizer's COVID pill - Israel News - Haaretz.com
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab | Ctech
Pfizer is releasing a generic Viagra as its patent expires — Quartz
Teva Takes Pfizer and BMS to Court Over Blood Thinner UK Patents - IP News Shots
Teva to produce coronavirus drug under Pfizer patent – The Observatorial
Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout | Reuters.com
Pfizer in $2.15 Billion Settlement From Teva and Sun for Patent Infringement
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | Fierce Pharma
Pfizer sues Teva over arthritis treatment
Pfizer and Teva face new drug delay action - Global Competition Review
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | Fierce Pharma
Patexia - Pfizer vs Teva was a big case between generic and brand drugmakers, and was the first time when damages were paid for the creation and selling of a generic brand
Pfizer reaches $2 billion Protonix settlement with Teva and Sun Pharma - The Economic Times
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
